[et_pb_section][et_pb_row][et_pb_column type=”4_4″][et_pb_text]
Vosoritide is a longer-acting C-type natriuretic peptide (CNP) analog that modulates activity of the fibroblast growth factor receptor 3 (FGFR3) by inhibiting a signaling pathway that mediates its effects, thereby stimulating endochondrial growth, resulting in enhanced growth velocity. It is proposed for the treatment of achondroplasia.
If you have a Hayes login, click here to view the full report on the Knowledge Center.
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]